The role of drug-metabolising enzymes in clinical responses to chemotherapy

By Scripture Charity D   Figg William D   Sparreboom Alex  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Iss. 1, 2006-02 ,pp. : 17-25

Informa Healthcare

Access to resources Recommend Favorite

Genetic Polymorphisms of Drug-Metabolising Enzymes and Drug Transporters in the Chemotherapeutic Treatment of Cancer

By Bosch Tessa M.  

Clinical Pharmacokinetics, Vol. 45, Iss. 3, 2006-01 ,pp. : 253-285

Adis International

Access to resources Recommend Favorite

Orphan Nuclear Receptors as Targets for Drug Development

By Mukherjee Subhajit   Mani Sridhar  

Pharmaceutical Research, Vol. 27, Iss. 8, 2010-08 ,pp. : 1439-1468

Springer Publishing Company

Access to resources Recommend Favorite

Nuclear Receptors as Drug Targets: New Developments in Coregulators, Orphan Receptors and Major Therapeutic Areas

By Sladek Frances M  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 5, 2003-10 ,pp. : 679-684

Informa Healthcare

Access to resources Recommend Favorite

Novel Orphan Nuclear Receptors-Coregulator Interactions Controlling Anti-Cancer Drug Metabolism

By  

Current Drug Metabolism, Vol. 9, Iss. 7, 2008-09 ,pp. : 611-613

Bentham Science Publishers

Access to resources Recommend Favorite